| Ansøgningsnr. og dato | 17786774.4 (espacenet) (Federated) (European Patent Register), 20170421 | | Patent/reg.nr. og dato | DK/EP 3445368, 20240717 | | Tilgængelighedsdato | 20190227 | | Prioritetsnr. og dato | US 201662325860 P, 20160421 | | EP publ. nr. og dato |
EP 3445368 20190227 | | Løbedag | | | Ansøger/indehaver | The U.S.A. As Represented By The Secretary,
Department Of Health And Human Services, National Institues of Health
6011 Executive Boulevard Suite 325
MSC 7660
Bethesda, MD 20892-7660, US,
Board of Regents, The University of Texas System, 210 West 7th Street
Austin, TX 78701, US,
Astrocyte Pharmaceuticals, Inc., 245 First Street Suite 1800
Cambridge, Massachusetts 02142, US | | Ansøgers ref. nr. | | | Opfinder | JACOBSON, Kenneth A., 11218 Watermill Lane
Silver Spring
Maryland 20902, US,
KORINEK, William S., 163 Long Wharf Drive
Mystic
Connecticut 06355, US,
LECHLEITER, James D., 112 Martha Glynn Court
San Antonio
Texas 78213, US,
LISTON, Theodore E., 33 Kidds Way
Stonington
Connecticut 06378, US | | Fuldmægtig | | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/519 (2006.01) , A61K 31/52 (2006.01) , A61K 31/7076 (2006.01) , A61P 25/00 (2006.01) , A61P 9/00 (2006.01) | | Titel/benævnelse | COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS | | Internationalt ansøgningsnr. | US2017028996 | | Internationalt publ. nr. | WO2017185061 | | Relateret sag (certifikat) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
